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A 51-year-old healthy sportsman was admitted with a history of
transient fever and non-itchy exanthema all over his body, sparing
the oral mucosa (Figure 1) (Jordan et al., 2016). His haemodynamic
parameters were normal. The patient denied a history of chills,
unusual sexual contact, trauma, or tick bites, but reported a recent
forest walk and swimming in the river with his dog. The dog, which
had remained in good health, had probably caused him a minor
injury. With a clinical suspicion of borreliosis (ﬁrst serology
negative), we administered oral doxycycline 100 mg twice daily
empirically. The next day he left hospital and we received the
results of the blood cultures: Capnocytophaga canimorsus. Due to
his excellent clinical progress, we continued doxycycline and
added amoxicillin–clavulanic acid without switching to intrave-
nous therapy, both for another 3 weeks. There were two reasons for
adding another oral antimicrobial drug. The ﬁrst was the
uncertainty regarding the clinical efﬁcacy of oral doxycycline for
Capnocytophaga bacteremia. Although aminopenicillins are the
usual recommended ﬁrst-line agents for C. canimorsus (Jolivet-
Gougeon et al., 2007; Sotiriou et al., 2015), numerous reports have
stated its susceptibility to doxycycline (Jolivet-Gougeon et al.,
2007) and to many other drugs, while most strains remain
resistant to polymyxins, fosfomycin, and trimethoprim (Jolivet-
Gougeon et al., 2007). The second reason was the limited
experience of oral doxycycline for the treatment of bacteremia
that has been reported so far in combination with gentamicin for
Bartonella or Brucella spp (Fruchtman et al., 2015). The exanthema,
which was different from the usual livedo racemosa seen in
C. canimorsus sepsis (Sotiriou et al., 2015), disappeared and the
Figure 1. Non-itchy exanthema all over the patient’s body, sparing the oral mucosa.
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control serology for Borrelia remained negative. The patient has
reported being in good health 1.5 years after the infection. We
share the photos of the patient’s exanthema associated with
C. canimorsus bacteremia (Jordan et al., 2016).
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